ATE148454T1 - Neuen vitamin d derivate - Google Patents

Neuen vitamin d derivate

Info

Publication number
ATE148454T1
ATE148454T1 AT94903741T AT94903741T ATE148454T1 AT E148454 T1 ATE148454 T1 AT E148454T1 AT 94903741 T AT94903741 T AT 94903741T AT 94903741 T AT94903741 T AT 94903741T AT E148454 T1 ATE148454 T1 AT E148454T1
Authority
AT
Austria
Prior art keywords
pct
compounds
thiol
sec
derivatives
Prior art date
Application number
AT94903741T
Other languages
English (en)
Inventor
Gunnar Grue-Sorensen
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE148454T1 publication Critical patent/ATE148454T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94903741T 1992-12-23 1993-12-17 Neuen vitamin d derivate ATE148454T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226877A GB9226877D0 (en) 1992-12-23 1992-12-23 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE148454T1 true ATE148454T1 (de) 1997-02-15

Family

ID=10727157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903741T ATE148454T1 (de) 1992-12-23 1993-12-17 Neuen vitamin d derivate

Country Status (15)

Country Link
US (1) US5554599A (de)
EP (1) EP0675878B1 (de)
KR (1) KR100295977B1 (de)
AT (1) ATE148454T1 (de)
AU (1) AU668638B2 (de)
CA (1) CA2146775C (de)
DE (1) DE69307929T2 (de)
DK (1) DK0675878T3 (de)
ES (1) ES2098123T3 (de)
FI (1) FI108225B (de)
GB (1) GB9226877D0 (de)
GR (1) GR3022774T3 (de)
NZ (1) NZ259317A (de)
RU (1) RU2136660C1 (de)
WO (1) WO1994014766A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
WO1995027697A1 (fr) * 1994-04-11 1995-10-19 Chugai Seiyaku Kabushiki Kaisha Derive de la 22-thiavitamine d¿3?
KR100382262B1 (ko) 1995-12-28 2003-08-25 쥬가이 세이야쿠 가부시키가이샤 악성종양전이억제제
US6869940B2 (en) 1995-12-28 2005-03-22 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6184398B1 (en) 1996-12-20 2001-02-06 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin D derivatives
DK0947504T3 (da) * 1996-12-20 2003-11-24 Chugai Pharmaceutical Co Ltd 16-en-vitamin D-derivater
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DK1180035T3 (da) 1999-04-01 2007-03-05 Univ Johns Hopkins Ikke kalcemiske, antiproliferative, transkriptionsmæssigt aktive svovlholdige analoger af 1-alpha, 25-dihydroxy-vitamin D3
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
ATE294585T1 (de) 1999-09-29 2005-05-15 Colotech As Vorbeugung von kolorektalkrebs
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
AU2001248777A1 (en) * 2000-04-19 2001-10-30 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivatives
TWI288131B (en) 2000-06-15 2007-10-11 Chugai Pharmaceutical Co Ltd Vitamin D derivative, compounds pharmaceutical composition thereof
DE60231987D1 (de) * 2001-08-22 2009-05-28 Univ Johns Hopkins 24-schwefel-substituierte 1-alpha-25-dihydroxy-vitamin-d3-analogen
PL210795B1 (pl) * 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
US7101865B2 (en) 2002-06-13 2006-09-05 Cytochroma Inc. 24-sulfoximine vitamin D3 compounds
US8106035B2 (en) 2002-12-18 2012-01-31 Cytochroma Inc. 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3
AU2010208323B2 (en) 2009-01-27 2016-03-10 Berg Llc Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy
EP2464357B1 (de) 2009-08-14 2019-05-22 Berg LLC Vitamin d3 und analoge davon zur behandlung von alopezie
KR20160013201A (ko) 2013-05-29 2016-02-03 버그 엘엘씨 비타민 d를 이용한 화학요법 유발 탈모증의 예방 또는 완화

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
WO1995027697A1 (fr) * 1994-04-11 1995-10-19 Chugai Seiyaku Kabushiki Kaisha Derive de la 22-thiavitamine d¿3?

Also Published As

Publication number Publication date
DE69307929T2 (de) 1997-09-04
RU95113480A (ru) 1997-03-20
AU668638B2 (en) 1996-05-09
RU2136660C1 (ru) 1999-09-10
CA2146775C (en) 2005-06-28
GB9226877D0 (en) 1993-02-17
ES2098123T3 (es) 1997-04-16
AU5808794A (en) 1994-07-19
FI952972A0 (fi) 1995-06-16
FI108225B (fi) 2001-12-14
CA2146775A1 (en) 1994-07-07
DK0675878T3 (da) 1997-04-28
NZ259317A (en) 1997-05-26
KR100295977B1 (ko) 2001-11-14
US5554599A (en) 1996-09-10
EP0675878A1 (de) 1995-10-11
GR3022774T3 (en) 1997-06-30
KR950703501A (ko) 1995-09-20
DE69307929D1 (de) 1997-03-13
FI952972A (fi) 1995-06-16
WO1994014766A1 (en) 1994-07-07
EP0675878B1 (de) 1997-01-29

Similar Documents

Publication Publication Date Title
DE69307929D1 (de) Neuen vitamin d derivate
ATE138069T1 (de) Schwefel enthaltende kondensierte pyrimidinderivate, ihre herstellung und verwendung
NO953305L (no) Antranilsyrederivat
ATE37180T1 (de) 1-carbonyl-1-phenyl-2-azolyl-ethanol derivate als mikrobizide und wuchsregulatoren, sowie ihre zwischenprodukte.
NO930974D0 (no) Fremstilling og anvendelse av triazolpyridazinforbindelser
HK1054373A1 (en) Vitamin d derivatives possessing a 22-oxa or 22-thia atom, a c17-side chain substituted by an acid, ester or amide group and a 16(17)-double bond
SU633479A3 (ru) Способ получени стильбеновых соединений
ATE116650T1 (de) Sulfonylamin substituierte bizyklische hydroxansäurederivate.
FI86057B (fi) 2-bensyltio- eller 2-bensylsulfoxid-1- cyklopenten-1-karboxamider, foerfaranden foer deras framstaellning och deras anvaendning vid syntes av 4,5-trimetylen-4-isotiazolin-3-oner.
Fitt et al. Lithiation of N, N-dimethyl-3-(phenylthio)-2-propenylamine
IE903448A1 (en) Benzanilides
HU199113B (en) Process for production of new derivatives of 2,3-diamin-acryl-acid-nitril
GB1445595A (en) 4-aminoquinoline derivatives and intermediates for their pre paration
KR850001173A (ko) 2-치환된 4-페닐이미다졸 아미딘 유도체의 제조방법
NZ241117A (en) Sulphonylaminoalkylphenylalkylamine derivatives; preparatory processes and pharmaceutical compositions
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
DE69316392D1 (de) Azanoradamantane
HUP0003059A2 (hu) Eljárás 2-alkiltiobenzoesav-származékok előállítására
CA1135267A (en) Oxidation of alpha-alkylated, benzyl-substituted 2-thiopyridine 1-oxides
SU698511A3 (ru) Гербицидна композици
AU6520698A (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
GB1221389A (en) 2,4-dicyano-6-nitrobenzene derivatives
SU1216183A1 (ru) Способ получени ,цис,цис-3-тиа-1,4-пентадиен-1,5-дикарбоновой кислоты или ее динатриевой соли
JP2002220370A (ja) スルフェンアミド化合物の製造方法
JPS591460A (ja) ２−メルカプトエチルアミンハロゲン化水素酸塩類の製造方法

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee